Search filters

List of works by Alessio Aghemo

A 13-day, interferon-free regimen for chronic hepatitis C genotype 1 patients: between fear and hope

scientific article published on 26 May 2011

A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

scientific article published on 2 July 2012

A review of the treatment of chronic hepatitis C virus infection in cirrhosis

scientific article

Acute tubular necrosis following interferon-based therapy for hepatitis C: case study with literature review.

scientific article published on January 2013

Allelic inhibition of displacement activity: a simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms.

scientific article published on 29 November 2012

Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management

scientific article published on 22 December 2011

Assessing long-term treatment efficacy in chronic hepatitis B and C: between evidence and common sense.

scientific article published on 28 June 2012

Cirrhosis regression in chronic hepatitis C: an old tale with a new ending

scientific article published on 24 January 2009

Clinical drivers in naïve patient eligibility for treatment of chronic hepatitis C.

scientific article published in January 2012

Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection

scientific article published on 11 January 2014

Commentary: absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C.

scientific article

Comparative trials of peginterferon α2a and peginterferon α2b for chronic hepatitis C ⬇️

scientific article published on January 1, 2012

Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis

scientific article

De novo membrano-proliferative nephritis following interferon therapy for chronic hepatitis C (case study and literature review).

scientific article published on 08 December 2013

Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method

scientific article published in July 2010

Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation.

scientific article published in November 2010

Directly acting antivirals for the treatment of chronic hepatitis C: unresolved topics from registration trials.

scientific article published on 12 June 2012

Do gamma-glutamyltransferase levels identify HCV patients who require lifelong post-SVR follow-up?

scientific article published on 01 March 2020

Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis?

scientific article published on 23 March 2011

Editorial: should we abandon HCV genotype testing? Maybe.

scientific article published in April 2019

Eukaryotic initiation factor 5B: a new player for the anti-hepatitis C virus effect of ribavirin?

scientific article published on 21 July 2012

Feasibility and reproducibility of spleen transient elastography and its role in combination with liver transient elastography for predicting the severity of chronic viral hepatitis

scientific article published on 5 June 2013

Gastrointestinal involvement attenuates COVID-19 severity and mortality

scientific article published on 09 September 2020

Genetic variation in interleukin-28B predicts hepatitis C treatment-induced viral clearance in genotype 1 patients: the dawn of a new era?

scientific article published on 01 June 2010

Genetic variation in the interleukin -28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection

article

HBV and HCV therapy.

scientific article

HCV genotype 3: an independent predictor of fibrosis progression in chronic hepatitis C.

scientific article published on 19 August 2009

HCV screening: Moving from theory to practice

scientific article published on 01 July 2020

Hepatitis C genotype 3: a tough match for interferon-free regimens

scientific article published on 22 February 2014

Hepatitis C treatment in patients with kidney disease.

scientific article published on 03 July 2013

Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy.

scientific article published on 3 October 2009

Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.

scientific article published on 22 July 2012

Hepatorenal syndrome and novel advances in its management

scientific article published on 05 December 2013

High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma

scientific article published on 03 May 2018

High levels of factor VIII and risk of extra-hepatic portal vein obstruction

scientific article

How to optimize HCV therapy in genotype 2 patients ⬇️

scientific article published on February 1, 2013

Hyporesponsiveness to PegIFNα2B plus ribavirin in patients with hepatitis C-related advanced fibrosis

scientific article published on 12 July 2011

Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation

scientific article published on 29 September 2013

Implications of PNPLA3 polymorphism in chronic hepatitis C patients receiving peginterferon plus ribavirin

scientific article published on 24 April 2012

Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies

scientific article published on March 2013

Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy.

scientific article published on 24 June 2013

Insulin resistance and response to telaprevir plus pegylated interferon and ribavirin: a requiem for the HOMA score?

scientific article published on 13 October 2012

Interaction between IL28B and PNPLA3 genotypes in the pathogenesis of steatosis in chronic hepatitis C non genotype-3 patients

scientific article published on 08 January 2012

Interferon in the treatment of chronic hepatitis C: a drug caught between past and future.

scientific article

Interferon-free oral therapy for hepatitis C: "faraway, so close!"

scientific article published on 19 March 2012

Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4.

scientific article published on 3 January 2012

Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?

scientific article published on 6 March 2008

Is there need for more than one IL28B single nucleotide polymorphism in hepatitis C clinical practice?

scientific article published on 01 January 2013

Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis

scientific article published on 12 July 2008

Low rates of naturally occurring resistant variants to the NS5A inhibitor daclatasvir in HCV-1 null responders

scientific article published on 4 February 2013

Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection

scientific article published on 14 March 2013

New horizons in hepatitis C antiviral therapy with direct-acting antivirals.

scientific article published on 31 May 2013

Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

scientific article published on 11 February 2011

PegIFN-α2a for the treatment of chronic hepatitis B and C: a 10-year history.

scientific article published on May 2013

Peginterferon Alfa-2B versus peginterferon Alfa-2A with ribavirin for the treatment of chronic hepatitis C: the pursuit of an ideal

scientific article published on 20 November 2009

Peginterferon maintenance therapy in patients with advanced hepatitis C to prevent hepatocellular carcinoma: the plot thickens

scientific article published on 23 July 2011

Pegylated IFN-alpha2a and ribavirin in the treatment of hepatitis C.

scientific article published on October 2009

Pegylated interferons alpha2a and alpha2b in the treatment of chronic hepatitis C.

scientific article published on 20 July 2010

Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score

scientific article

Post-liver transplantation graft biopsies should not be used to assess the IL28B donor genotype in HCV recipients

scientific article published on 28 January 2012

Postsustained Virological Response Management in Hepatitis C Patients

scientific article published on 27 February 2020

Predictors of psychopathological outcome during peg-interferon and ribavirin therapy in patients with chronic HCV-correlated hepatitis.

scientific article published on 31 December 2012

Randomized study of peginterferon-alpha2a plus ribavirin vs peginterferon-alpha2b plus ribavirin in chronic hepatitis C.

scientific article published on 18 September 2009

Recovery after L-DOPA treatment in peginterferon and ribavirin induced parkinsonism

scientific article published on 28 November 2007

Ribavirin Impairs Salivary gland function During Combination Treatment With Pegylated Interferon Alfa-2a In HEpatitis C patients.

scientific article published on 30 November 2011

Ribavirin suppresses erythroid differentiation and proliferation in chronic hepatitis C patients

scientific article published on 15 August 2013

Sarcopenia in chronic liver disease: easy to diagnose but hard to treat

scientific article published on 01 November 2020

Selection of resistant-associated variants to the NS5A inhibitor daclatasvir: revenge of the hepatitis C virus

scientific article published on 29 May 2013

Should Artificial Intelligence‐based language models be allowed in developing scientific manuscripts? A debate between <scp>ChatGPT</scp> and the editors of <i>Liver International</i>

scientific article published in 2023

Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C.

scientific article published on 14 October 2012

Telaprevir for hepatitis C re-treatment: an open door on a long and winding road

scientific article published on 21 August 2010

The clinical impact of a 24-week treatment course of peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia.

scientific article published on 9 February 2006

The course of esophageal varices in patients with hepatitis C cirrhosis responding to interferon/ribavirin therapy.

scientific article published in January 2011

The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirin

scientific article published in January 2009

The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response.

scientific article published on 23 March 2013

The optimal ribavirin dose for patients infected with hepatitis C virus genotype 3: should we utilize more?

scientific article published on February 2009

The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosis

scientific article published in December 2007

Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma: considerations on the efficacy of treatment with fresh-frozen plasma

scientific article published on 5 February 2011

Treatment of chronic hepatitis C with pegylated interferon-α in a patient with recurrent autoimmune thrombotic thrombocytopenic purpura.

scientific article published on 29 October 2012

Treatment of experienced and naïve patients with hepatitis C: focus on telaprevir.

scientific article published on 18 October 2012

Treatment of nonresponder patients with chronic hepatitis C: to repeat or not to repeat? That is the question

scientific article published on 28 August 2009

Treatment of patients with HCV related cirrhosis: many rewards with very few risks.

scientific article

Treatment of patients with dual hepatitis B and C: a step in the right direction

scientific article published on 6 August 2013

Triple therapy with first-generation protease inhibitors for patients with genotype 1 chronic hepatitis C: recommendations of the Italian association for the study of the liver (AISF)

scientific article

Twelve-week posttreatment follow-up predicts a sustained virological response to pegylated interferon and ribavirin therapy.

scientific article published in September 2010

US features of liver surface nodularity as a predictor of severe fibrosis in chronic hepatitis C

scientific article published on 01 February 2005

Understanding the Role of PNPLA3 Genetic Variants in Patients with Chronic Hepatitis C Infection ⬇️

scientific article published on June 27, 2012

Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study

scientific article published on 30 October 2020

Paulina is supported by:

About Paulina

Help